FDA recalls over half a million Theragun PRO G4 chargers due to fire risk

The US Food and Drug Administration has announced a recall of more than 584,000 Theragun PRO G4 chargers after reports of overheating, smoke, and fire risks. The recall affects certain models sold with the Theragun PRO and refurbishments, with regulators warning consumers to avoid using affected units while Therabody investigates.

The US Food and Drug Administration has warned that more than 584,000 Theragun PRO G4 chargers have been recalled because of a risk of overheating, smoking and fire. According to the FDA, Therabody received reports that some units caught fire and others produced visible smoke, melted, gave off a burning smell or became excessively hot.

The recall covers fourth-generation chargers sold with the Theragun PRO and several refurbished and single-unit charger products. Therabody said the affected items can be identified by specific stock keeping units, including G4 PRO Black US – Refurb, G4 PRO NA, G4-PRO-PKG-US, G4 PRO Black US – Refurb V and Pro Charger Single Unit. The chargers can also be matched by the device identifiers UDI-DI 00810036050135 and GTIN 810036051378.

The FDA classed the recall as Class II, which covers products that may cause temporary or medically reversible harm. Therabody has told distributors and resellers to remove the chargers from sale, while the company is still assessing the issue. The FDA said it has not yet issued consumer instructions, but anyone with concerns can seek virtual support through Therabody’s website.

The episode adds to a growing number of safety actions involving consumer charging products, a category that has drawn close scrutiny from regulators because of the fire and burn risks associated with overheating lithium-ion systems. The FDA’s recalls database and medical device safety pages are the main public record for such actions and are routinely used by consumers and researchers to track the status of recalled products.